☰
✕

Endocrine testing market

Endocrine Testing Product Market, by Product Type (Instruments/Analyzers and Consumables), by Technology (Liquid Chromatography-Mass Spectrometry, Immunoassay, Monoclonal and Polyclonal Antibody, Electrochemical/Biosensor (Sensor), and Clinical Chemistry), by Test Type (Adrenocorticotropic Hormone (ACTH), Calcitonin, Calcium, Cortisol, Catecholamine, Dehydroepiandrosterone Sulfate (DHEA-S), Estradiol, Follicle Stimulating Hormone, Growth Hormone, Luteinizing Hormone, Prolactin, Progesterone, Testosterone, Thyroid Stimulating Hormone, Vitamin D, and Others), by Disease Indication (Adrenal Insufficiency and Addison Disease, Bone Disorders, Cancer (Tumor), Infertility, Renal Diseases, Metabolic (Including Diabetes) and Gastrointestinal Disorders, Pituitary Disorders, Thyroid Disease, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, Satellite Laboratories, Commercial Labs, Home Care Settings, and Ambulatory Care Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample
  • May 2022
  • CMI1755
  • 208 Pages
  • Excel & Pdf
  • Clinical Diagnostic

Endocrine systems consist of various glands, which release specific hormones into the bloodstream in human body. These hormones are carried with the blood throughout the body and control various functions of the body such as metabolism, growth and development, reproduction, stimuli response, and homeostasis. The endocrine system consists of various glands such as hypothalamus, pancreas, adrenal glands, thyroid, and pituitary gland. The hormones secreted by these glands are used to maintain various biological functions in the human system. Therefore, an imbalance in the concentrations of hormones in human system may lead to certain conditions, like weight gain, muscle weakness etc. Endocrine testing consists of diagnosis of concentration of endocrine hormones in human system such as estradiol, testosterone, progesterone, insulin, thyroid, luteinizing, cortisol DHEA-S, prolactin, follicle stimulating hormone, human chorionic gonadotropin, and hormone. The testing helps to understand the concentration of specific hormones in the blood.

Global Endocrine Testing Products Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to increase the growth of the global endocrine testing products market, owing to the increase in the number of patients suffering from hormonal conditions, post COVID-19 infection. For instance, according to the article published in the Frontiers in Nutrition Journal, published in March 2021, there has been increase in the number of patients suffering from hormonal imbalance post-COVID-19 infection. This can be observed as the number of patients visiting the hospitals for the treatment of hormonal condition is increasing. According to the same source, there has been an impact on the pathophysiology and management of diabetes (both outpatient and inpatient) as well as pituitary, adrenal, thyroid, bone, and gonadal function, in post COVID-19 patients.

COVID-19 has completely altered both the clinical practice and the social relationships. Many organs and biological systems are affected by SARS-CoV-2 infection, either directly from virus damage or indirectly through effects that can have systemic consequences. The endocrine system is not only an exception, but its involvement in COVID-19 is so significant that an ‘endocrine phenotype’ of COVID-19 has gradually gained clinical relevance. For instance, according to an article published in Endocrine journal, May 2021, diabetes plays a significant role in this phenotype because it is one of the most common comorbidities associated with COVID-19 severity and mortality. Careful management, including treatment modifications, may be required to protect patients suffering from endocrine diseases from the most dangerous consequences of COVID-19, not only in those with known diabetes or those hospitalized with COVID-19, but also in those with SARS-CoV-2 induced newly onset diabetes.

Moreover, according to the same source, lack of vitamin D, hypocalcaemia, and vertebral fractures have also emerged as common findings in the hospitalized COVID-19 population, which may interfere with their treatment. Additionally, in patients with adrenal insufficiency, glucocorticoid doses may need to be adjusted right away.

The global endocrine testing products market is estimated to be valued at US$ 11,695.7 Mn in 2022 and is expected to exhibit a CAGR of 8.9% over the forecast period (2022-2030)  

Figure 1: Global Endocrine Testing Products Market Share, (%), Analysis, By Product, 2022

 

Market players are indulged in inorganic activities such as acquisition, in order to enhance company’s product portfolio. This is expected to drive growth of the global endocrine testing products market over the forecast period.

Market players are engaged in the inorganic activities such as acquisitions and this is expected to drive growth of the global endocrine testing products market over the forecast period. For instance, in March 2021, Roche, a Swiss multinational healthcare company and GenMark Diagnostics, a molecular diagnostics company, announced a definitive merger agreement in which Roche will fully acquire GenMark Diagnostics for US$ 24.05 per share in an all-cash transaction. As a result of this acquisition, GenMark's syndromic panel testing portfolio will complement Roche's current molecular diagnostics portfolio.

Increasing product launches by the market players is expected to drive the growth of the global endocrine testing products market over the forecast period

Product launches by the market players is expected to drive growth of the global endocrine testing products market over the forecast period. For instance, in March 2020, Agilent Technologies Inc., an American analytical instrumentation, officially launched the Agilent K6460S Clinical Edition TQ LC/MS system, which is intended to improve in vitro diagnostic workflows in clinical laboratories. The K6460S, Agilent's next-generation clinical edition triple quadrupole liquid chromatography-mass spectrometry (LC/MS) system, is classified as a Class I medical device by the U.S. Food and Drug Administration. Moreover, in June 2019, Abbott Laboratories, an American multinational medical devices and health care company, launched Afinion HbA1c Dx assay to be operated on Afinion 2 Analyzer and Afinion AS100 Analyzer for the diagnosis of diabetes and identification of patients at the risk of developing diabetes.

Endocrine Testing Products Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 11,695.7 Mn
Historical Data for: 2018 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 8.9% 2030 Value Projection: US$ 23,160.1 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Instruments/Analyzers, Consumables
  • By Technology: Liquid Chromatography-Mass Spectrometry, Immunoassay, Monoclonal and Polyclonal Antibody, Electrochemical/Biosensor (Sensor), Clinical Chemistry
  • By Test Type: Adrenocorticotropic Hormone (ACTH), Calcitonin, Calcium, Cortisol, Catecholamine, Dehydroepiandrosterone Sulfate (DHEA-S), Estradiol, Follicle Stimulating Hormone, Growth Hormone, Luteinizing Hormone, Prolactin, Progesterone, Testosterone, Thyroid Stimulating Hormone, Vitamin D, Others
  • By Disease Indication: Adrenal Insufficiency and Addison Disease, Bone Disorders, Cancer (Tumor), Infertility, Renal Diseases, Metabolic (Including Diabetes) and Gastrointestinal Disorders, Pituitary Disorders, Thyroid Disease, Others
  • By End User: Hospitals & Clinics, Diagnostic Laboratories, Satellite Laboratories, Commercial Labs, Home Care Settings, Ambulatory Care Centers
Companies covered:

F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp),  Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc.  
Growth Drivers:
  • Increasing inorganic activities such as acquisitions by the market players
  • Increasing product launches by the market players
  • Increasing research and development activities by the market players
Restraints & Challenges:
  • Unaffordable technologies to the emerging and underdeveloped economies

Global Endocrine Testing Products Market – Restraints

Most of the underdeveloped regions cannot afford new technologies for endocrine testing, which is expected to hamper the growth of the global endocrine testing products market. For instance, the technological advancements in diagnostic testing systems and test kits have resulted in high cost of these products. Test kits for endocrine testing alone cost anywhere between US$ 100 to US$ 700-800. Several countries in emerging regions such as Latin America, Asia Pacific, Middle East, and Africa are not in a position to afford implementation of advanced technologies (such as use of monoclonal and polyclonal antibodies in diagnostic practice/for assay development) in clinical practice. Moreover, owing to underdeveloped healthcare infrastructure, conventional diagnostic testing techniques are performed in several countries of these regions, especially in North and Central Africa and Asia Pacific. These factors are expected to restrain the growth of the global endocrine testing products market growth over the forecast period.

Global Endocrine Testing Products Market – Regional Analysis

On the basis of region, global endocrine testing products market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Among regions, North America endocrine testing products market is expected to hold a dominant position during the forecast period, owing to the inorganic strategies such as partnerships. For instance, in 2020, Ro, the healthcare technology company, and Quest Diagnostics, a manufacturer of diagnostic products, entered into strategic partnership to add diagnostic capabilities and lab testing facilities to Ro's primary care platform. This partnership will support Ro’s expansion in the U.S. by providing solutions for diagnosis, treatment, and management of chronic and complex medical conditions using the platform.

Furthermore, Europe is also estimated to witness significant growth in the global endocrine testing products market, owing to increasing research and development activities by the organizations. European Cluster to improve Identification of endocrine disruptors (EURION Cluster) has eight research projects, which are focusing on ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’. The projects received a funding of US$ 55.9 million from the EU Horizon 2020 Research and Innovation Program.

Figure 2: Global Endocrine Testing Products Market (US$ Mn), by Region, 2022

Global Endocrine Testing Products Market – Competitive Landscape

Major players operating in the global endocrine testing products market include F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp),  Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc.   

 

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Technology
      • Market Snippet, By Test Type
      • Market Snippet, By Disease Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • PEST Analysis
    • Recent Product Launch/Approval
    • Epidemiology
    • Mergers and Acquisitions
  4. Global Endocrine Testing Products Market - Impact of Coronavirus (Covid-19) Pandemic
    • Impact on Supply Chain
    • Impact on Research and Development
    • Government Initiatives
  5. Global Endocrine Testing Products Market, By Product Type, 2017-2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Instruments/Analyzers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  6. Global Endocrine Testing Products Market, By Technology, 2017 - 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Liquid Chromatography-Mass Spectrometry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Immunoassay
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Monoclonal and Polyclonal Antibody
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Electrochemical/Biosensor (Sensor)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Clinical Chemistry
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  7. Global Endocrine Testing Products Market, By Test Type, 2017 - 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Adrenocorticotropic Hormone (ACTH)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Calcitonin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Calcium
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Cortisol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Catecholamine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Dehydroepiandrosterone Sulfate (DHEA-S)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Estradiol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Follicle Stimulating Hormone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Growth Hormone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Luteinizing Hormone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Prolactin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Progesterone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Testosterone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Thyroid Stimulating Hormone
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Vitamin D
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  8. Global Endocrine Testing Products Market, By Disease Indication, 2017 - 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Adrenal Insufficiency and Addison Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Bone Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Cancer (Tumor)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Infertility
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Renal Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Metabolic (Including Diabetes) and Gastrointestinal Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Pituitary Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Thyroid Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  9. Global Endocrine Testing Products Market, By End User, 2017 - 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Diagnostic Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Satellite Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Commercial Labs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
    • Ambulatory Care Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
  10. Global Endocrine Testing Products Market, By Region, 2017 - 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2022 and 2030 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018 - 2030
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Technology, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Test Type, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Disease Indication, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By End User, 2017 - 2030 (US$ Mn)
      • Market Size and Forecast, By Country, 2017 - 2030 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  11. Competitive Landscape
    • Company Profiles
      • Hoffmann-La Roche Ltd.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Agilent Technologies
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • BioMerieux S.A.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Bio-Rad Laboratories, Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Siemens Healthineers
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Danaher Corporation
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • DiaSorin S.p.A.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Immunodiagnostic Systems
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Laboratory Corporation of America Holdings (LabCorp)
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Fujirebio, Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Thermo Fisher Scientific Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Quest Diagnostics
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Sysmex Corporation
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • MP Biomedicals
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Ortho Clinical Diagnostics
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
      • Meridian Life Science, Inc.
        • Company Overview
        • Drug Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Strategies
    • Analyst Views
  12. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 39 market data tables and 25 figures on "Global Endocrine Testing Products Market” - Forecast to 2030.

Detailed Segmentation:

  • Global Endocrine Testing Products Market, By Product Type:
    • Instruments/Analyzers
    • Consumables
  • Global Endocrine Testing Products Market, By Technology:
    • Liquid Chromatography-Mass Spectrometry
    • Immunoassay
    • Monoclonal and Polyclonal Antibody
    • Electrochemical/Biosensor (Sensor)
    • Clinical Chemistry
  • Global Endocrine Testing Products Market, By Test Type:
    • Adrenocorticotropic Hormone (ACTH)
    • Calcitonin
    • Calcium
    • Cortisol
    • Catecholamine
    • Dehydroepiandrosterone Sulfate (DHEA-S)
    • Estradiol
    • Follicle Stimulating Hormone
    • Growth Hormone
    • Luteinizing Hormone
    • Prolactin
    • Progesterone
    • Testosterone
    • Thyroid Stimulating Hormone
    • Vitamin D
    • Others
  • Global Endocrine Testing Products Market, By Disease Indication:
    • Adrenal Insufficiency and Addison Disease
    • Bone Disorders
    • Cancer (Tumor)
    • Infertility
    • Renal Diseases
    • Metabolic (Including Diabetes) and Gastrointestinal Disorders
    • Pituitary Disorders
    • Thyroid Disease
    • Others
  • Global Endocrine Testing Products Market, By End User:
    • Hospitals & Clinics
    • Diagnostic Laboratories
    • Satellite Laboratories
    • Commercial Labs
    • Home Care Settings
    • Ambulatory Care Centers
  • Global Endocrine Testing Products Market, By Region:
    • North America
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Instruments/Analyzers
        • Consumables
      • By Technology:
        • Liquid Chromatography-Mass Spectrometry
        • Immunoassay
        • Monoclonal and Polyclonal Antibody
        • Electrochemical/Biosensor (Sensor)
        • Clinical Chemistry
      • By Test Type:
        • Adrenocorticotropic Hormone (ACTH)
        • Calcitonin
        • Calcium
        • Cortisol
        • Catecholamine
        • Dehydroepiandrosterone Sulfate (DHEA-S)
        • Estradiol
        • Follicle Stimulating Hormone
        • Growth Hormone
        • Luteinizing Hormone
        • Prolactin
        • Progesterone
        • Testosterone
        • Thyroid Stimulating Hormone
        • Vitamin D
        • Others
      • By Disease Indication:
        • Adrenal Insufficiency and Addison Disease
        • Bone Disorders
        • Cancer (Tumor)
        • Infertility
        • Renal Diseases
        • Metabolic (Including Diabetes) and Gastrointestinal Disorders
        • Pituitary Disorders
        • Thyroid Disease
        • Others
      • By End User:
        • Hospitals & Clinics
        • Diagnostic Laboratories
        • Satellite Laboratories
        • Commercial Labs
        • Home Care Settings
        • Ambulatory Care Centers
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What will be the compound annual growth rate (CAGR) for the global endocrine testing products market during the forecast period (2022-2030)?

The global endocrine testing products market is expected to exhibit a CAGR of 8.9% during the forecast period (2022-2030).

What is the estimated market size of the market in 2022?

The market is estimated to be valued at US$ 11,695.7 Mn in 2022.

Which are the prominent players operating in the market across the globe?

F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp),  Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc. are some of the prominent players operating in the market.

What are the growth estimates for the market till 2030?

The market is expected to be valued at US$ 23,160.1 Mn in 2030.

Which are the prominent regions in the market?

North America is the prominent region in the market.

Which is the prominent segment among the product segment, in the market?

Consumables is the prominent segment among the product type segment in the market.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now